Trial intelligence / Profile preview

MN-221 in Acute Asthma Exacerbation

NCT00683449Phase 2Terminated

Sponsor
MediciNova, Inc.
Start
Jun 2008
Primary completion
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bedoradrine in asthma, sponsored by MediciNova, Inc.. Started Jun 2008; status: terminated.

02

Drugs

bedoradrine
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00683449.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00683449.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call